Lysoway Therapeutics, Inc., a biotechnology company advancing structure-guided small-molecule modulators of lysosomal ion ...

Kyocera Corporation (President: Hideo Tanimoto; "Kyocera")(TOKYO: 6971) announced that it has developed a new meta-lens that uses metasurface-based optical control technology to precisely manipulate ...

Company Continues Market Education on Microbiome-Based Memory Function and Mental Clarity Following September Launch; New ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

High power LED lighting is harder than it looks. Power, dimming, control, and communication collide in one design.

Genethon, a worldwide pioneer and leader in research and development of gene therapies for rare genetic diseases, announced today Angela Columbano, Director of Business Development and Partnership, ...

As chip manufacturing scales up, water supply and wastewater treatment systems are under immense pressure. Cutting-edge ...

Ikarovec Ltd, which is developing dual-pathway gene therapies for vision-threatening retinal diseases, and VectorBuilder, a global leader in gene delivery technologies, have entered into an exclusive ...

Santa Barbara-based Lucidean, a deep-tech startup working at the cutting edge of optical interconnect technologies, has ...

The analyses of progression-free survival (PFS) and overall survival (OS) remain on track for late Q1 2026 in the ongoing Phase 2/3 COMPANION-002 ...

Companies like Kairos Energy are building new types of reactors with the encouragement of the Trump administration, but their ...

Ad hoc announcement pursuant to Art. 53 LR Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is ...